Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Salarius Pharmaceuticals (NASDAQ:SLRX) through any online brokerage.
Other companies in Salarius Pharmaceuticals’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Can Fite Biofarma Ltd (AMEX:CANF), AquaBounty Technologies Inc (NASDAQ:AQB), Indaptus Therapeutics Inc (NASDAQ:INDP) and Protagenic Therapeutics Inc (NASDAQ:PTIX).
There is no analysis for Salarius Pharmaceuticals to provide a consensus price target.
The stock price for Salarius Pharmaceuticals (NASDAQ: SLRX) is $0.798 last updated December 15, 2025 at 8:37 AM EST.
There are no upcoming dividends for Salarius Pharmaceuticals.
Salarius Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Salarius Pharmaceuticals.
Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.